Market Highlights - 13 May, 2020
Book Trial for 2 days - Whatsapp 9841986753
Book Trial for 2 days - Whatsapp 9841986753
KEEP REFRESH FOR NEXT UPDATE
💎 Closing Bell: Sensex gains 637.49 points to close at 32008.61; Nifty ends 187 points higher at 9383.55.
💎 NMDC reduces prices of ore lumps and fines by Rs.400 per tonne to Rs.2,250 per tonne.
💎 Aurobindo Pharma receives USFDA approval for Ibuprofen tablets & Azelastine Hydrochloride nasal spray.
💎 Anil Kumar Pillai resigns as Chief Financial Officer in Brooks Laboratories.
💎 IndiaMart InterMesh Q4FY20 PAT jumps 57% at Rs.44 crore.
💎 Buena Vista Fund sold 5,64,381 shares of Healthcare Global at Rs.85.41 per share.
💎 Asian Agro bought 1,19,194 shares in Asian Hotels (North) at Rs.59.44 per share.
💎 Jubilant Life Sciences signs a deal with Gilead for production of Remdesivir and will have rights to sell Remdesivir to 127 countries.
💎 Market ends at a 2-week high after Rs 20 lakh crore economic package announcement by PM Modi
💎 Sensex and Nifty gain 2 percent each while Nifty Bank surges more than 4 percent
💎 Nifty emds 187 points higher 9,384 and Sensex 637 points higher at 32,009
💎 Nifty Bank gains 772 points to 19,635 and midcap 293 points to 13,064
💎 Financials contribute over 60 percent to Nifty; HDFC twins, ICICI top gainers
💎 Except pharma and FMCG, all close higher; PSU Bank top gaining index
💎 45 Nifty stocks close higher; Zee Entertainment, Adani Ports, Axis Bank and L&T top gainers
💎 Nestle declines 5 percent despite reporting earnings better than expectations
💎 Kotak Mahindra Bank up 3 percent after reporting operationally strong earnings
💎 Maruti Suzuki slips from highs after lower-than-expected Q4 earnings
💎 Jubilant LifeSciences advances 5 percent after an agreement with Gilead for COVID-19 drug
Whatsapp Number : 91-9094047040 / 91-9841986753
Book Trial for 2 days - Whatsapp 9841986753
Currency USDINR Tips
Currency USDINR Tips
Commodity CRUDEOIL Tips
Index Nifty and Stock Options Tips
Register for 2 days Trial - Whatsapp - 9841986753
No comments:
Post a Comment